Literature DB >> 31529274

Combination of Chemical and Neurotrophin Stimulation Modulates Neurotransmitter Receptor Expression and Activity in Transdifferentiating Human Adipose Stromal Cells.

Arthur A Nery1, Ricardo L Pereira1, Vinicius Bassaneze2, Isis C Nascimento1, Lauren S Sherman3, Pranela Rameshwar3, Claudiana Lameu1, Henning Ulrich4.   

Abstract

Adipose stromal cells are promising tools for clinical applications in regeneration therapies, due to their ease of isolation from tissue and its high yield; however, their ability to transdifferentiate into neural phenotypes is still a matter of controversy. Here, we show that combined chemical and neurotrophin stimulation resulted in neuron-like morphology and regulated expression and activity of several genes involved in neurogenesis and neurotransmission as well as ion currents mediated by NMDA and GABA receptors. Among them, expression patterns of genes coding for kinin-B1 and B2, α7 nicotinic, M1, M3 and M4 muscarinic acetylcholine, glutamatergic (AMPA2 and mGlu2), purinergic P2Y1 and P2Y4 and GABAergic (GABA-A, β3-subunit) receptors and neuronal nitric oxide synthase were up-regulated compared to levels of undifferentiated cells. Simultaneously, expression levels of P2X1, P2X4, P2X7 and P2Y6 purinergic and M5 muscarinic acetylcholine receptors were down-regulated. Agonist-induced activity levels of the studied receptor classes also augmented during neuronal transdifferentiation. Transdifferentiated cells expressed high levels of neuronal β3-tubulin, NF-H, NeuN and MAP-2 proteins as well as increased ASCL1, MYT1 and POU3F2 gene expression known to drive neuronal fate determination. The presented work contributes to a better understanding of transdifferentiation induced by neurotrophins for a prospective broad spectrum of medical applications.

Entities:  

Keywords:  Adipose stromal cells; Human lipoaspirate; Mesenchymal stem cells; Neuronal differentiation; Transdifferentiation

Year:  2019        PMID: 31529274     DOI: 10.1007/s12015-019-09915-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  73 in total

1.  Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells.

Authors:  Ernesto Lujan; Soham Chanda; Henrik Ahlenius; Thomas C Südhof; Marius Wernig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism.

Authors:  Jia Liu; Atsushi Kuwabara; Yoshinobu Kamio; Shuling Hu; Jeonghyun Park; Tomoki Hashimoto; Jae-Woo Lee
Journal:  Stem Cells       Date:  2016-07-08       Impact factor: 6.277

Review 3.  Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection.

Authors:  Alice Laroni; Nicole Kerlero de Rosbo; Antonio Uccelli
Journal:  Immunol Lett       Date:  2015-08-18       Impact factor: 3.685

Review 4.  Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence.

Authors:  Dannie Macrin; Joel P Joseph; Aruthra Arumugam Pillai; Arikketh Devi
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

5.  Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates.

Authors:  Moritz Mall; Michael S Kareta; Soham Chanda; Henrik Ahlenius; Nicholas Perotti; Bo Zhou; Sarah D Grieder; Xuecai Ge; Sienna Drake; Cheen Euong Ang; Brandon M Walker; Thomas Vierbuchen; Daniel R Fuentes; Philip Brennecke; Kazuhiro R Nitta; Arttu Jolma; Lars M Steinmetz; Jussi Taipale; Thomas C Südhof; Marius Wernig
Journal:  Nature       Date:  2017-04-05       Impact factor: 49.962

6.  Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation.

Authors:  Micheli M Pillat; Claudiana Lameu; Cleber A Trujillo; Talita Glaser; Angélica R Cappellari; Priscilla D Negraes; Ana M O Battastini; Telma T Schwindt; Alysson R Muotri; Henning Ulrich
Journal:  J Cell Sci       Date:  2016-08-15       Impact factor: 5.285

7.  Differentiation of human adipose stem cells into neural phenotype by neuroblastoma- or olfactory ensheathing cells-conditioned medium.

Authors:  Debora Lo Furno; Rosalia Pellitteri; Adriana C E Graziano; Rosario Giuffrida; Carlo Vancheri; Elisa Gili; Venera Cardile
Journal:  J Cell Physiol       Date:  2013-11       Impact factor: 6.384

8.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

9.  Positive feedback regulation between gamma-aminobutyric acid type A (GABA(A)) receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons.

Authors:  Christophe Porcher; Caroline Hatchett; Rebecca E Longbottom; Kristina McAinch; Talvinder S Sihra; Stephen J Moss; Alex M Thomson; Jasmina N Jovanovic
Journal:  J Biol Chem       Date:  2011-04-07       Impact factor: 5.157

10.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

View more
  1 in total

1.  Mouse Neural Stem Cell Differentiation and Human Adipose Mesenchymal Stem Cell Transdifferentiation Into Neuron- and Oligodendrocyte-like Cells With Myelination Potential.

Authors:  Anderson K Santos; Katia N Gomes; Ricardo C Parreira; Sérgio Scalzo; Mauro C X Pinto; Helton C Santiago; Alexander Birbrair; Ulrich Sack; Henning Ulrich; Rodrigo R Resende
Journal:  Stem Cell Rev Rep       Date:  2021-11-15       Impact factor: 5.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.